TD-3504
- Generic Name
- TD-3504
TD-3504 SAD in Healthy Subjects and Subjects With Ulcerative Colitis (UC)
Phase 1
Completed
- Conditions
- Active Mild Ulcerative Colitis, Active Moderate Ulcerative Colitis, Healthy Subjects
- Interventions
- First Posted Date
- 2017-04-06
- Last Posted Date
- 2021-01-14
- Lead Sponsor
- Theravance Biopharma
- Target Recruit Count
- 32
- Registration Number
- NCT03103412
- Locations
- 🇺🇸
Anaheim Clinical Trials, LLC, Anaheim, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath